Re: [177Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ENZA-p): An Open-label, Multicentre, Randomised, Phase 2 Trial
Details
Publication Year 2024-12,Volume 86,Issue #6,Page 595-596
Journal Title
European Urology
Publication Type
Commentary
Publisher
Elsevier
Department(s)
Surgical Oncology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-01-07 06:20:56
Last Modified: 2025-01-07 06:21:10
An error has occurred. This application may no longer respond until reloaded. Reload 🗙